Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation

Journal of the American College of Cardiology

Volumn 59, Issue 2, 2012, Pages 178-188

  Amat Santos, Ignacio J ^a   Rodés Cabau, Josep ^a   Urena, Marina ^a   DeLarochellière, Robert ^a   Doyle, Daniel ^a   Bagur, Rodrigo ^a   Villeneuve, Jacques ^a   Côté, Mélanie ^a   Nombela Franco, Luis ^a   Philippon, François ^a   Pibarot, Philippe ^a   Dumont, Eric ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

atrial fibrillation; stroke; transapical; transcatheter aortic valve implantation; transcatheter aortic valve replacement; transfemoral

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ELECTROCARDIOGRAM; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM SIZE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; EMBOLISM; ENDOVASCULAR PROCEDURES; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUEBEC; RISK FACTORS;

EID: 84855347288     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.09.061     Document Type: Article

References (32)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-98.
3. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
4. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
5. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
6. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:229-308.
7. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204.
8. Walther T, Kasimir MT, Doss M, et al. One-year follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011;39:532-7.
9. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011;32:191-7.
10. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011;12:762-7.
11. Kaireviciute D, Aidietiset A, Lip GY. Atrial fibrillation following cardiac surgery: clinical features and preventive strategies. Eur Heart J 2009;30: 410-25.
12. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997;226:501-11.
13. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trial. A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.
14. Murdock DK, Rengel LR, Schlund A, et al. Stroke and atrial fibrillation following cardiac surgery. WMJ 2003;102:26-30. (Pubitemid 37012778)
15. Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;57:223-42.
16. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines. Reg Anesth Pain Med 2010;35:64-101.
17. Dahl JS, Videbaek L, Poulsen MK, et al. Noninvasive assessment of filling pressure and left atrial pressure overload in severe aortic valve stenosis: relation to ventricular remodeling and clinical outcome after aortic valve replacement. J Thorac Cardiovasc Surg 2011;142:e77-83.
18. Casaclang-Verzosa G, Malouf JF, Scott CG, Juracan EM, Nishimura RA, Pellikka PA. Does left atrial size predict mortality in asymptomatic patients with severe aortic stenosis? Echocardiography 2010;27:105-9.
19. Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006;47:2357-63. (Pubitemid 43866385)
20. Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006;151:412-8. (Pubitemid 43144744)
21. Wachtell K, Gerdts E, Aurigemma GP, et al. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Blood Press 2010;19:169-75.
22. Osranek M, Fatema K, Qaddoura F, et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 2006;48:779-86. (Pubitemid 44175728)
23. Zacà V, Galderisi M, Mondillo S, Focardi M, Ballo P, Guerrini F. Left atrial enlargement as a predictor of recurrences in lone parxysmal atrial fibrillation. Can J Cardiol 2007;23:869-72. (Pubitemid 350011266)
24. Ravelli F, Masè M, del Greco M, Marini M, Disertoni M. Acute atrial dilatation slows conduction and increases AF vulnerability in the human atrium. J Cardiovasc Electrophysiol 2011;22:394-401.
25. Onaitis M, D'Amico T, Zhao Y, O'Brien S, Harpole D. Risk factors for atrial fibrillation after lung cancer surgery: analysis of the society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg 2010;90:368-74.
26. Tisdale JE, Wroblewski HA, Kesler KA, et al. Prophylaxis of atrial fibrillation after noncardiac thoracic surgery. Semin Thorac Cardiovasc Surg 2010;22:310-20.
27. Rodés-Cabau J, Gutiérrez M, Bagur R, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011;57:1988-99.
28. Halonen J, Loponen P, Järvinen O, et al. Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial. Ann Intern Med 2010;153:703-9.
29. Kahlert P, Doettger P, Mori K, et al. Cerebral embolization during transcatheter aortic valve implantation (TAVI): a transcranial Doppler study [abstr]. Circulation 2010;122:e525-5.
30. Mitchell LB, CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol 2011;27:91-7.
31. Green L, Machin SJ. Managing anticoagulated patients during neuraxial anaesthesia. Br J Haematol 2010;149:195-208.
32. Liu SS, Buvanendran A, Viscusi ER, et al. Uncomplicated removal of epidural catheters in 4365 patients with international normalized ratio greater than 1.4 during initiation of warfarin therapy. Reg Anesth Pain Med 2011;36:231-5.